BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25051916)

  • 21. N-Acetyltransferase-2 genetic polymorphism, well-done meat intake, and breast cancer risk among postmenopausal women.
    Deitz AC; Zheng W; Leff MA; Gross M; Wen WQ; Doll MA; Xiao GH; Folsom AR; Hein DW
    Cancer Epidemiol Biomarkers Prev; 2000 Sep; 9(9):905-10. PubMed ID: 11008907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-acetyltransferase 2 polymorphism is associated with bladder cancer risk: An updated meta-analysis based on 54 case-control studies.
    Song Y; Qi X; Liu X
    Gene; 2020 Oct; 757():144924. PubMed ID: 32622992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between N-acetyltransferase 2 (NAT2) genetic polymorphism and development of breast cancer in post-menopausal Chinese women in Taiwan, an area of great increase in breast cancer incidence.
    Huang CS; Chern HD; Shen CY; Hsu SM; Chang KJ
    Int J Cancer; 1999 Jul; 82(2):175-9. PubMed ID: 10389748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Possible association of NAT2 polymorphism with laryngeal cancer risk: an evidence-based meta-analysis.
    Ying XJ; Dong P; Shen B; Wang J; Wang S; Wang G
    J Cancer Res Clin Oncol; 2011 Nov; 137(11):1661-7. PubMed ID: 21877196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cigarette smoking, N-acetyltransferase 2 genotypes, and breast cancer risk: pooled analysis and meta-analysis.
    Ambrosone CB; Kropp S; Yang J; Yao S; Shields PG; Chang-Claude J
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):15-26. PubMed ID: 18187392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pilot study investigating the role of NAT1 and NAT2 polymorphisms in gastric adenocarcinoma.
    Boissy RJ; Watson MA; Umbach DM; Deakin M; Elder J; Strange RC; Bell DA
    Int J Cancer; 2000 Aug; 87(4):507-11. PubMed ID: 10918189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A meta-analysis of the association of N-acetyltransferase 2 gene (NAT2) variants with breast cancer.
    Ochs-Balcom HM; Wiesner G; Elston RC
    Am J Epidemiol; 2007 Aug; 166(3):246-54. PubMed ID: 17535831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of CYP2E1 and NAT2 polymorphisms with lung cancer susceptibility among Mongolian and Han populations in the Inner Mongolian region.
    Zhang JW; Yu WJ; Sheng XM; Chang FH; Bai TY; Lv XL; Wang G; Liu SZ
    Asian Pac J Cancer Prev; 2014; 15(21):9203-10. PubMed ID: 25422202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modifying Effect of Smoking on GSTM1 and NAT2 in Relation to the Risk of Bladder Cancer in Mongolian Population: A Case-Control Study.
    Avirmed S; Khuanbai Y; Sanjaajamts A; Selenge B; Dagvadorj BU; Ohashi M
    Asian Pac J Cancer Prev; 2021 Aug; 22(8):2479-2485. PubMed ID: 34452561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NAT2 slow acetylation and bladder cancer risk: a meta-analysis of 22 case-control studies conducted in the general population.
    Marcus PM; Vineis P; Rothman N
    Pharmacogenetics; 2000 Mar; 10(2):115-22. PubMed ID: 10761999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of slow acetylator genotype of N-acetyltransferase 2 with Parkinson's disease in south Indian population.
    Pandi S; Chinniah R; Sevak V; Ravi PM; Vijayan M; Vellaiappan NA; Karuppiah B
    Neurosci Lett; 2020 Sep; 735():135260. PubMed ID: 32682841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis.
    Moore LE; Baris DR; Figueroa JD; Garcia-Closas M; Karagas MR; Schwenn MR; Johnson AT; Lubin JH; Hein DW; Dagnall CL; Colt JS; Kida M; Jones MA; Schned AR; Cherala SS; Chanock SJ; Cantor KP; Silverman DT; Rothman N
    Carcinogenesis; 2011 Feb; 32(2):182-9. PubMed ID: 21037224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Glutathione S-transferases (GSTM1, GSTT1 and GSTP1) and N-acetyltransferase 2 polymorphisms and the risk of gastric cancer].
    Hong SH; Kim JW; Kim HG; Park IK; Ryoo JW; Lee CH; Sohn YK; Lee JY
    J Prev Med Public Health; 2006 Mar; 39(2):135-40. PubMed ID: 16615268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-acetyltransferase 2 phenotype, occupation, and bladder cancer risk: results from the EPIC cohort.
    Pesch B; Gawrych K; Rabstein S; Weiss T; Casjens S; Rihs HP; Ding H; Angerer J; Illig T; Klopp N; Bueno-de-Mesquita B; Ros MM; Kaaks R; Chang-Claude J; Roswall N; Tjønneland A; Overvad K; Clavel-Chapelon F; Boutron-Ruault MC; Dossus L; Boeing H; Weikert S; Trichopoulos D; Palli D; Sieri S; Tumino R; Panico S; Quirós JR; González C; Sánchez MJ; Dorronsoro M; Navarro C; Barricarte A; Ljungberg B; Johansson M; Ulmert D; Ehrnström R; Khaw KT; Wareham N; Key TJ; Ferrari P; Romieu I; Riboli E; Brüning T; Vineis P
    Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):2055-65. PubMed ID: 24092628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NAT2 polymorphism in Omani gastric cancer patients-risk predisposition and clinicopathological associations.
    Al-Moundhri MS; Al-Kindi M; Al-Nabhani M; Al-Bahrani B; Burney IA; Al-Madhani A; Ganguly SS; Tanira M
    World J Gastroenterol; 2007 May; 13(19):2697-702. PubMed ID: 17569138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NAT2 slow acetylation and bladder cancer in workers exposed to benzidine.
    Carreón T; Ruder AM; Schulte PA; Hayes RB; Rothman N; Waters M; Grant DJ; Boissy R; Bell DA; Kadlubar FF; Hemstreet GP; Yin S; LeMasters GK
    Int J Cancer; 2006 Jan; 118(1):161-8. PubMed ID: 16003747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 'Comparison of extremes' approach provides evidence against the modifying role of NAT2 polymorphism in lung cancer susceptibility.
    Belogubova EV; Kuligina ESh; Togo AV; Karpova MB; Ulibina JM; Shutkin VA; Hanson KP; Popowski K; Mosyagin I; Cascorbi I; Hirvonen A; Imyanitov EN
    Cancer Lett; 2005 Apr; 221(2):177-83. PubMed ID: 15808403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glutathione S-transferase (GST) M1, T1 and N-acetyltransferase 2 (NAT2) polymorphisms and urothelial cancer risk with tobacco smoking.
    Tsukino H; Nakao H; Kuroda Y; Imai H; Inatomi H; Osada Y; Katoh T
    Eur J Cancer Prev; 2004 Dec; 13(6):509-14. PubMed ID: 15548945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of NAT2 polymorphism and methylation in anti-tuberculosis drug-induced liver injury in Mongolian tuberculosis patients.
    Zhang D; Hao J; Hou R; Yu Y; Hu B; Wei L
    J Clin Pharm Ther; 2020 Jun; 45(3):561-569. PubMed ID: 32364660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strong association between N-acetyltransferase 2 genotype and PD in Hong Kong Chinese.
    Chan DK; Lam MK; Wong R; Hung WT; Wilcken DE
    Neurology; 2003 Mar; 60(6):1002-5. PubMed ID: 12654968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.